ClinicalTrials.govpublic full text
Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
b acute lymphoblastic leukemia, cd19 positive, minimal residual disease, philadelphia chromosome positive, recurrent adult acute lymphoblastic leukemia, recurrent childhood acute lymphoblastic leukemia, refractory acute lymphoblastic leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 966179
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.